Cargando…
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
Bladder cancer (BC) is the most common neoplasia of the urothelial tract. Due to its high incidence, prevalence, recurrence and mortality, it remains an unsolved clinical and social problem. The treatment of BC is challenging and, although immunotherapies have revealed potential benefit in a percent...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902278/ https://www.ncbi.nlm.nih.gov/pubmed/31850055 http://dx.doi.org/10.3389/fgene.2019.01125 |